E. Dogan Et Al. , "Evaluation of cardiac safety of lapatinib therapy for c-erbB2 amplified metastatic breast cancer," JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15, 2011
Dogan, E. Et Al. 2011. Evaluation of cardiac safety of lapatinib therapy for c-erbB2 amplified metastatic breast cancer. JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15 .
Dogan, E., Yorgun, H., Petekkaya, I., Ozer, N., Altundag, K., & Ozisik, Y. Y., (2011). Evaluation of cardiac safety of lapatinib therapy for c-erbB2 amplified metastatic breast cancer. JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15.
Dogan, E. Et Al. "Evaluation of cardiac safety of lapatinib therapy for c-erbB2 amplified metastatic breast cancer," JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15, 2011
Dogan, E. Et Al. "Evaluation of cardiac safety of lapatinib therapy for c-erbB2 amplified metastatic breast cancer." JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15, 2011
Dogan, E. Et Al. (2011) . "Evaluation of cardiac safety of lapatinib therapy for c-erbB2 amplified metastatic breast cancer." JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15.
@article{article, author={E. Dogan Et Al. }, title={Evaluation of cardiac safety of lapatinib therapy for c-erbB2 amplified metastatic breast cancer}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2011}